PROKIDNEY CP (PROK)
(Delayed Data from NSDQ)
$2.53 USD
-0.05 (-1.97%)
Updated Apr 23, 2024 04:00 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for ProKidney Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -135.45 | -148.14 | -2.32 | -26.75 | NA |
Depreciation/Amortization & Depletion | 3.85 | 3.04 | 0.00 | 0.96 | NA |
Net Change from Assets/Liabilities | 16.67 | -6.46 | 1.12 | -0.13 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 24.85 | 74.47 | 0.00 | 0.73 | NA |
Net Cash From Operating Activities | -90.07 | -77.09 | -1.21 | -25.18 | NA |
Property & Equipment | -34.20 | -1.85 | 0.00 | -5.46 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | -295.79 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.11 | -250.00 | 0.00 | NA |
Net Cash from Investing Activities | -329.98 | -1.74 | -250.00 | -5.46 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -9.50 | 0.00 | 245.60 | 0.00 | NA |
Issuance (Repayment) of Debt | -0.05 | -0.03 | -0.39 | -0.01 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.40 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 548.55 | 6.04 | 20.00 | NA |
Net Cash from Financing Activities | -9.55 | 548.52 | 251.65 | 19.99 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -429.60 | 469.69 | 0.44 | -10.65 | NA |
Cash at Beginning of Period | 490.25 | 20.56 | 0.00 | 15.23 | NA |
Cash at End of Period | 60.65 | 490.25 | 0.44 | 4.58 | NA |
Diluted Net EPS | -0.57 | -0.23 | -0.11 | NA | NA |
Fiscal Year End for ProKidney Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -135.45 | -113.72 | -71.73 | -36.91 |
Depreciation/Amortization & Depletion | NA | 3.85 | 2.71 | 1.70 | 0.83 |
Net Change from Assets/Liabilities | NA | 16.67 | 12.77 | 6.88 | -2.45 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 24.85 | 33.56 | 22.24 | 12.53 |
Net Cash From Operating Activities | NA | -90.07 | -64.69 | -40.91 | -25.99 |
Property & Equipment | NA | -34.20 | -32.63 | -4.69 | -0.99 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -295.79 | -201.51 | -201.08 | -191.63 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -329.98 | -234.14 | -205.77 | -192.61 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -9.50 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | -0.05 | -0.04 | -0.03 | -0.01 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -9.55 | -0.04 | -0.03 | -0.01 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -429.60 | -298.86 | -246.70 | -218.62 |
Cash at Beginning of Period | NA | 490.25 | 490.25 | 490.25 | 490.25 |
Cash at End of Period | NA | 60.65 | 191.39 | 243.55 | 271.64 |
Diluted Net EPS | NA | -0.09 | -0.18 | -0.14 | -0.16 |